Gene · 11091
Papers2,554
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,554
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arabidopsis SEC13B Interacts with Suppressor of Frigida 4 to Repress Flowering. | Int J Mol Sci | 2023 | 38139079 | PubTator, text mining | PubMed |
| Targeted therapies in bladder cancer: signaling pathways, applications, and challenges. | MedComm (2020) | 2023 | 38107059 | PubTator, text mining | PubMed |
| Nanopore Single-molecule Analysis of Biomarkers: Providing Possible Clues to Disease Diagnosis. | Trends Analyt Chem | 2023 | 38106545 | PubTator, text mining | PubMed |
| Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors. | J Med Chem | 2023 | 38085679 | PubTator, text mining | PubMed |
| Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. | Signal Transduct Target Ther | 2023 | 38072908 | PubTator, text mining | PubMed |
| A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. | BMC Gastroenterol | 2023 | 38066437 | PubTator, text mining | PubMed |
| WD repeat domain 5 promotes the development of late-onset preeclampsia by activating nuclear factor kappa B. | Acta Cir Bras | 2023 | 38055397 | PubTator, text mining | PubMed |
| Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research. | Front Mol Biosci | 2023 | 38028543 | PubTator, text mining | PubMed |
| Identification of two novel autism genes, TRPC4 and SCFD2, in Qatar simplex families through exome sequencing. | Front Psychiatry | 2023 | 38025430 | PubTator, text mining | PubMed |
| Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer. | Explor Target Antitumor Ther | 2023 | 38023987 | PubTator, text mining | PubMed |
| Role and therapeutic potential of DEAD-box RNA helicase family in colorectal cancer. | Front Oncol | 2023 | 38023215 | PubTator, text mining | PubMed |
| Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer. | Genome Biol | 2023 | 38012744 | PubTator, text mining | PubMed |
| Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications. | Pharmaceuticals (Basel) | 2023 | 38004481 | PubTator, text mining | PubMed |
| Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues. | Int J Mol Sci | 2023 | 38003507 | PubTator, text mining | PubMed |
| In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). | Int J Mol Sci | 2023 | 38003223 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Potential Targets for Diagnosis and Treatment of Oral Lichen Planus: A Narrative Review. | Biomolecules | 2023 | 38002328 | PubTator, text mining | PubMed |
| New insights into the regulation of METTL3 and its role in tumors. | Cell Commun Signal | 2023 | 37996892 | PubTator, text mining | PubMed |
| Augmenting L3MBTL2-induced condensates suppresses tumor growth in osteosarcoma. | Sci Adv | 2023 | 37992172 | PubTator, text mining | PubMed |
| An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer. | Noncoding RNA | 2023 | 37987366 | PubTator, text mining | PubMed |
| Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival. | Cell Commun Signal | 2023 | 37974198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11091/papers?page=11